Related references
Note: Only part of the references are listed.Potential targeting of FLT3 acute myeloid leukemia
Alexander J. Ambinder et al.
HAEMATOLOGICA (2021)
Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT
Loredana Ruggeri et al.
BONE MARROW TRANSPLANTATION (2021)
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes
Gregory Ehx et al.
IMMUNITY (2021)
Checkpoint inhibitors in AML: are we there yet?
Arnab Ghosh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies
Darren C. Phillips et al.
LEUKEMIA (2020)
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation
Pier Edoardo Rovatti et al.
FRONTIERS IN IMMUNOLOGY (2020)
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
Dietrich Wilhelm Beelen et al.
LANCET HAEMATOLOGY (2020)
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study
Effie W. Petersdorf et al.
LANCET HAEMATOLOGY (2020)
FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Eduardo Rodriguez-Arboli et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN)
Andreas Burchert et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy
Jacopo Mariotti et al.
BLOOD ADVANCES (2020)
Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans
Franziska M. Uhl et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation
Awais Ijaz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Catherine J. Lee et al.
BONE MARROW TRANSPLANTATION (2019)
Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies
Yu-Lin Zhang et al.
ANNALS OF HEMATOLOGY (2019)
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
Cristina Toffalori et al.
NATURE MEDICINE (2019)
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
Maddalena Noviello et al.
NATURE COMMUNICATIONS (2019)
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1
Christopher P. Mill et al.
BLOOD (2019)
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
Rafael F. Duarte et al.
BONE MARROW TRANSPLANTATION (2019)
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
Lucas P. Wachsmuth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Olle Ringden et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
Jorge E. Cortes et al.
LANCET ONCOLOGY (2019)
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Anna M. Paczulla et al.
NATURE (2019)
Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation
Alice Bertaina et al.
FRONTIERS IN IMMUNOLOGY (2019)
Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioninga matched pair analysis
Maximilian Doppelhammer et al.
ANNALS OF HEMATOLOGY (2019)
Mechanisms of immune escape after allogeneic hematopoietic cell transplantation
Robert Zeiser et al.
BLOOD (2019)
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
Christoph Schmid et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment
Christina Rautenberg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver et al.
LEUKEMIA (2019)
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Naval Daver et al.
CANCER DISCOVERY (2019)
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation
Max Jan et al.
BLOOD ADVANCES (2019)
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide
Shannon R. McCurdy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Stefan O. Ciurea et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor
Raphael Teipel et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Immune regulatory cell infusion for graft-versus-host disease prevention and therapy
Bruce R. Blazar et al.
BLOOD (2018)
Epidemiology and biology of relapse after stem cell transplantation
Mary Horowitz et al.
BONE MARROW TRANSPLANTATION (2018)
Comparable survival using a CMV-matched or a mismatched donor for CMV plus patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT
Simone Cesaro et al.
BONE MARROW TRANSPLANTATION (2018)
Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report
Jakob R. Passweg et al.
BONE MARROW TRANSPLANTATION (2018)
High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia
Nina K. Steckel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
Naval Daver et al.
LEUKEMIA (2018)
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nimitha R. Mathew et al.
NATURE MEDICINE (2018)
Molecular Minimal Residual Disease in Acute Myeloid Leukemia
M. Jongen-Lavrencic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Trichinella spiralis excretory-secretory Products induce Tolerogenic Properties in human Dendritic cells via Toll-like receptors 2 and 4
Natasa Ilic et al.
FRONTIERS IN IMMUNOLOGY (2018)
Potential Beneficial effects of Cytomegalovirus infection after Transplantation
Nicolle H. R. Litjens et al.
FRONTIERS IN IMMUNOLOGY (2018)
Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome
Francis Ayuk et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
M. J. Christopher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
Ying-Jun Chang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantation
Lori Muffly et al.
BLOOD ADVANCES (2018)
Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation
Jonathan Canaani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation
J. C. Albring et al.
BONE MARROW TRANSPLANTATION (2017)
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
Stefanie Goellner et al.
NATURE MEDICINE (2017)
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
Bart L. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
Simona Piemontese et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
R. M. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia
Maxim Norkin et al.
BLOOD CANCER JOURNAL (2017)
Combined venetoclax and alvocidib in acute myeloid leukemia
James Bogenberger et al.
ONCOTARGET (2017)
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation
Stefan O. Ciurea et al.
BLOOD (2017)
The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT
Luke Maggs et al.
BLOOD ADVANCES (2017)
HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities
Katharina Fleischhauer et al.
BLOOD (2017)
Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion
Franco Locatelli et al.
BLOOD (2017)
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
Mark A. Schroeder et al.
BLOOD (2017)
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide
Christopher G. Kanakry et al.
BLOOD (2017)
Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review
Sheila A. Fisher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation
Richard Greil et al.
CELL COMMUNICATION AND SIGNALING (2017)
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
Craig Kollman et al.
BLOOD (2016)
Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT
Bipin N. Savani et al.
HAEMATOLOGICA (2016)
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
J. M. Middeke et al.
LEUKEMIA (2016)
Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT
Bipin N. Savani et al.
HAEMATOLOGICA (2016)
Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia
Celalettin Ustun et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
M. Mielcarek et al.
BLOOD (2016)
Hematopoietic stem cell transplantation in Europe 2014: more than 40000 transplants annually
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2016)
Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
Eugene A. Zhukovsky et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Michael Byrne et al.
EXPERIMENTAL HEMATOLOGY (2016)
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?
Daisuke Araki et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
Matthew S. Davids et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide
Tara M. Robinson et al.
SEMINARS IN HEMATOLOGY (2016)
Impact of Donor Age on Outcome after Allogeneic Hematopoietic Cell Transplantation
Andrew R. Rezvani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Can a Female Donor for a Male Recipient Decrease the Relapse Rate for Patients with Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation?
Piyanuch Kongtim et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions-A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group
Thomas Schroeder et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study
Nelli Bejanyan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea et al.
BLOOD (2015)
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality
Antonella Mancusi et al.
BLOOD (2015)
FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation
Thomas Oellerich et al.
BLOOD (2015)
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2015)
Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective
F. Saraceni et al.
BONE MARROW TRANSPLANTATION (2015)
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients
P. Y. Yew et al.
BONE MARROW TRANSPLANTATION (2015)
Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation
Amir Horowitz et al.
JOURNAL OF IMMUNOLOGY (2015)
Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation
Andreas D. Orskov et al.
ONCOTARGET (2015)
Graft-versus-host disease versus graft-versus-leukemia
Robert S. Negrin
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2015)
DLI after haploidentical BMT with post-transplant CY
A. Ghiso et al.
BONE MARROW TRANSPLANTATION (2015)
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
R. B. Walter et al.
LEUKEMIA (2015)
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation
L. Crucitti et al.
LEUKEMIA (2015)
The IPD and IMGT/HLA database: allele variant databases
James Robinson et al.
NUCLEIC ACIDS RESEARCH (2015)
KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts
Sebastian U. Michaelis et al.
ANNALS OF HEMATOLOGY (2014)
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation
Marcos de Lima et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice
Sudipto Ganguly et al.
BLOOD (2014)
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
Massimo F. Martelli et al.
BLOOD (2014)
Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis
Nicolas Dulphy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2014)
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
Nicoletta Cieri et al.
BLOOD (2013)
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
Francis Mussai et al.
BLOOD (2013)
The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML
Nona Shayegi et al.
BLOOD (2013)
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT
R. Martino et al.
BONE MARROW TRANSPLANTATION (2013)
CD34+ lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT
F. Rosenow et al.
BONE MARROW TRANSPLANTATION (2013)
Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change
Maximilian Christopeit et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Transcriptional Regulation of IL-15 Expression during Hematopoiesis
Sara L. Colpitts et al.
JOURNAL OF IMMUNOLOGY (2013)
Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia
F. Stoelzel et al.
LEUKEMIA (2013)
Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies
E. H. Warren et al.
TISSUE ANTIGENS (2013)
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2012)
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
Oliver C. Goodyear et al.
BLOOD (2012)
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
S. M. Luger et al.
BONE MARROW TRANSPLANTATION (2012)
The EBMT activity survey: 1990-2010
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2012)
Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients
Beatriz Sanchez-Correa et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial
Martin Bornhaeuser et al.
LANCET ONCOLOGY (2012)
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study
Katharina Fleischhauer et al.
LANCET ONCOLOGY (2012)
Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy
V. Dubois et al.
LEUKEMIA (2012)
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
Jan J. Cornelissen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Claudio Anasetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
Leo Luznik et al.
SEMINARS IN ONCOLOGY (2012)
Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation
Friedrich Stoelzel et al.
TRANSPLANTATION (2012)
CD73: a potent suppressor of antitumor immune responses
Paul. A. Beavis et al.
TRENDS IN IMMUNOLOGY (2012)
Advances in graft-versus-host disease biology and therapy
Bruce R. Blazar et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia
Djordje Atanackovic et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation
Miguel Waterhouse et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation
Ginna G. Laport et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
Sebastian F. M. Haeusler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
Wieger J. Norde et al.
CANCER RESEARCH (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
Yvette L. Kasamon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
Jaebok Choi et al.
BLOOD (2010)
Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia
Oliver Goodyear et al.
BLOOD (2010)
Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse
S. Thiant et al.
BONE MARROW TRANSPLANTATION (2010)
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Michel Duval et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2009)
Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease
David Valcárcel et al.
CURRENT OPINION IN ONCOLOGY (2009)
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation
Martin Bornhaeuser et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials
John Koreth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Genetic Trickery -- Escape of Leukemia from Immune Attack.
John Barrett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation.
Luca Vago et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation
M. Stern et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Graft-versus-leukemia effects of transplantation and donor lymphocytes
Hans-Jochem Kolb
BLOOD (2008)
Donor lymphocyte infusion in the treatment of first Hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia:: A retrospective risk factors analysis and comparison with other strategies by the EBMT acute leukemia working party
Christoph Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia
B. N. Savani et al.
LEUKEMIA (2007)
Donor natural killer cell allorecognition of missing self in haploidentical hernatopoietic transplantation for acute myeloid leukemia: challenging its predictive value
Loredana Ruggeri et al.
BLOOD (2007)
Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts
Kozo Masuda et al.
CANCER SCIENCE (2007)
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat et al.
BLOOD (2007)
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
M Aoudjhane et al.
LEUKEMIA (2005)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Determinants of antileukemia effects of allogeneic NK cells
W Leung et al.
JOURNAL OF IMMUNOLOGY (2004)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-κB, c-myc, and pRb pathways
AGS Buggins et al.
JOURNAL OF IMMUNOLOGY (2001)
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
C Kollman et al.
BLOOD (2001)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
PD Kottaridis et al.
BLOOD (2001)
Share Paper
